The global Spasticity Market, valued at US$ 1.3 billion in 2024, is projected to grow at a compound annual growth rate (CAGR) of 8.4% from 2025 to 2035, surpassing US$ 3.2 billion by 2035. Spasticity, characterized by involuntary muscle stiffness and spasms, is associated with neurological conditions like multiple sclerosis, cerebral palsy, and stroke. Treatments include medications, physical...